It may take some time until we see generic semaglutide (Ozempic, Rybelsus, Wegovy) or generic tirzepatide (Mounjaro, Zepbound)likely in the early 2030s
Semaglutide is a temperature-sensitive glucagon-like peptide-1 (GLP-1) receptor agonist that requires specific storage conditions to maintain its structural integrity and therapeutic efficacy
With so many individuals now being prescribed GLP-1s for weight loss, shortages of the drugs have become chronic
However, IL-6 was reduced to control levels by the second visit
It can be used in dealing with tissue repair, anti-inflammation, antioxidant defense and angiogenesis
Managing common side effects GLP-1 medications share common side effects that can be managed effectively with the right approach